Nanotechnology approaches for inhalation treatment of lung diseases

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 500-518

  Kuzmov, Andriy ^a   Minko, Tamara ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Fibrosis; Gene delivery; Hypoxia; Lung cancer; Nanoparticles; Pulmonary delivery

Indexed keywords

BIOLOGICAL ORGANS; DRUG INTERACTIONS; GENE TRANSFER; NANOPARTICLES; NANOTECHNOLOGY; NUCLEIC ACIDS;

FIBROSIS; GENE DELIVERY; HYPOXIA; LUNG CANCER; PULMONARY DELIVERY;

DISEASES;

ANTIBODY; ANTINEOPLASTIC AGENT; AZACITIDINE; CAMPTOTHECIN; CISPLATIN; DENDRIMER; DOXORUBICIN; FLUOROURACIL; LIPID; LIPID BASED NANOPARTICLE; LIPOSOME; MAGNETIC NANOPARTICLE; MICROPARTICLE; NANOCARRIER; NANOPARTICLE; NANOSPHERE; NUCLEIC ACID; PACLITAXEL; POLYMER; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG; DRUG;

ARTICLE; ASTHMA; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COLLOIDAL DISPERSION; CYSTIC FIBROSIS; DEFENSE MECHANISM; DIAGNOSTIC IMAGING; DISPERSION; DRUG DELIVERY SYSTEM; DRUG INDUCED DISEASE; DRUG STABILITY; DRUG TARGETING; HUMAN; HYPERTHERMIA; HYPOXIA; INHALATION; INHALATIONAL DRUG ADMINISTRATION; LUNG CANCER; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG HYPOXIA; LUNG INJURY; LUNG METASTASIS; LUNG TOXICITY; LUNG TRANSPLANTATION; LUNG TUMOR; MYCOSIS; NANOTECHNOLOGY; NATURAL KILLER CELL; NONHUMAN; OCCUPATIONAL EXPOSURE; ORGAN DISTRIBUTION; PATENT; PHARMACEUTICS; PNEUMONIA; PRIORITY JOURNAL; RADIOSENSITIZATION; ANIMAL; LUNG DISEASES;

ADMINISTRATION, INHALATION; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LUNG DISEASES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 84947494382     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.07.024     Document Type: Article

References (159)

1. J.G. Chan, J. Wong, Q.T. Zhou, S.S. Leung, and H.K. Chan Advances in device and formulation technologies for pulmonary drug delivery AAPS PharmSciTech 15 2014 882 897
2. C. Cortez-Jugo, A. Qi, A. Rajapaksa, J.R. Friend, and L.Y. Yeo Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform Biomicrofluidics 9 2015 052603
3. M. Faiyazuddin, M. Mujahid, T. Hussain, H.H. Siddiqui, A. Bhatnagar, R.K. Khar, and F.J. Ahmad Aerodynamics and deposition effects of inhaled submicron drug aerosol in airway diseases Recent Patents Inflamm. Allergy Drug Discov. 7 2013 49 61
4. F. Gagnadoux, J. Hureaux, L. Vecellio, T. Urban, A. Le Pape, I. Valo, J. Montharu, V. Leblond, M. Boisdron-Celle, S. Lerondel, C. Majoral, P. Diot, J.L. Racineux, and E. Lemarie Aerosolized chemotherapy J. Aerosol Med. Pulm. Drug Deliv. 21 2008 61 70
5. B. Lehofer, F. Bloder, P.P. Jain, L.M. Marsh, G. Leitinger, H. Olschewski, R. Leber, A. Olschewski, and R. Prassl Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics Eur. J. Pharm. Biopharm. 88 2014 1076 1085
6. J.O. Morales, J.I. Peters, and R.O. Williams III Surfactants: their critical role in enhancing drug delivery to the lungs Ther. Deliv. 2 2011 623 641
7. R.B. Sagalla, and G.C. Smaldone Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition J. Aerosol Med. Pulm. Drug Deliv. 27 2014 341 348
8. S. Sharma, D. White, A.R. Imondi, M.E. Placke, D.M. Vail, and M.G. Kris Development of inhalational agents for oncologic use J. Clin. Oncol. 19 2001 1839 1847
9. S.R. Guma, D.A. Lee, Y. Ling, N. Gordon, and E.S. Kleinerman Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis Pediatr. Blood Cancer 61 2014 1362 1368
10. G. Hasenpusch, C. Pfeifer, M.K. Aneja, K. Wagner, D. Reinhardt, M. Gilon, P. Ohana, A. Hochberg, and C. Rudolph Aerosolized BC-819 inhibits primary but not secondary lung cancer growth PLoS One 6 2011 e20760
11. W. Hohenforst-Schmidt, P. Zarogoulidis, B. Linsmeier, I. Kioumis, Q. Li, H. Huang, D. Sachpatzidou, S. Lampaki, J. Organtzis, K. Domvri, L. Sakkas, G.A. Zachariadis, K.N. Archontas, A. Kallianos, A. Rapti, L. Yarmus, K. Zarogoulidis, and J. Brachmann Enhancement of aerosol cisplatin chemotherapy with gene therapy expressing ABC10 protein in respiratory system J. Cancer 5 2014 344 350
12. H.L. Jiang, S.H. Hong, Y.K. Kim, M.A. Islam, H.J. Kim, Y.J. Choi, J.W. Nah, K.H. Lee, K.W. Han, C. Chae, C.S. Cho, and M.H. Cho Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy Int. J. Pharm. 420 2011 256 265
13. A. Minai-Tehrani, Y.C. Park, S.K. Hwang, J.T. Kwon, S.H. Chang, S.J. Park, K.N. Yu, J.E. Kim, J.Y. Shin, J.H. Kim, B. Kang, S.H. Hong, and M.H. Cho Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice J. Vet. Sci. 12 2011 309 317
14. M.D. Reed, C.S. Tellez, M.J. Grimes, M.A. Picchi, M. Tessema, Y.S. Cheng, T.H. March, P.J. Kuehl, and S.A. Belinsky Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model Br. J. Cancer 109 2013 1775 1781
15. Y. Wang, K. Kho, W.S. Cheow, and K. Hadinoto A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles Int. J. Pharm. 424 2012 98 106
16. Y. Yang, W.S. Cheow, and K. Hadinoto Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles Int. J. Pharm. 434 2012 49 58
17. G. Mainelis, S. Seshadri, O.B. Garbuzenko, T. Han, Z. Wang, and T. Minko Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice J. Aerosol Med. Pulm. Drug Deliv. 26 2013 345 354
18. R. Savla, and T. Minko Nanotechnology approaches for inhalation treatment of fibrosis J. Drug Target. 21 2013 914 925
19. O.B. Garbuzenko, G. Mainelis, O. Taratula, and T. Minko Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention Cancer Biol. Med. 11 2014 44 55
20. O.B. Garbuzenko, M. Saad, S. Betigeri, M. Zhang, A.A. Vetcher, V.A. Soldatenkov, D.C. Reimer, V.P. Pozharov, and T. Minko Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug Pharm. Res. 26 2009 382 394
21. V. Ivanova, O.B. Garbuzenko, K.R. Reuhl, D.C. Reimer, V.P. Pozharov, and T. Minko Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2 Eur. J. Pharm. Biopharm. 84 2013 335 344
22. O. Taratula, O.B. Garbuzenko, A.M. Chen, and T. Minko Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA J. Drug Target. 19 2011 900 914
23. O. Taratula, A. Kuzmov, M. Shah, O.B. Garbuzenko, and T. Minko Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA J. Control. Release 171 2013 349 357
24. O.B. Garbuzenko, M. Saad, V.P. Pozharov, K.R. Reuhl, G. Mainelis, and T. Minko Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance Proc. Natl. Acad. Sci. U. S. A. 107 2010 10737 10742
25. O.B. Garbuzenko, J. Winkler, M.S. Tomassone, and T. Minko Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs Langmuir 30 2014 12941 12949
26. T. Minko, S.S. Dharap, R.I. Pakunlu, and Y. Wang Molecular targeting of drug delivery systems to cancer Curr. Drug Targets 5 2004 389 406
27. C.A. Ruge, J. Kirch, and C.M. Lehr Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges Lancet Respir. Med. 1 2013 402 413
28. M. Schwaiblmair, W. Behr, T. Haeckel, B. Markl, W. Foerg, and T. Berghaus Drug induced interstitial lung disease Open Respir. Med. J. 6 2012 63 74
29. P. Zarogoulidis, K. Darwiche, L. Yarmus, D. Spyratos, N. Secen, W. Hohenforst-Schmidt, N. Katsikogiannis, H. Huang, A. Gschwendtner, and K. Zarogoulidis Defense mechanisms of the respiratory system and aerosol production systems Med. Chem. 10 2014 123 136
30. S.P. Hertel, G. Winter, and W. Friess Protein stability in pulmonary drug delivery via nebulization Adv. Drug Deliv. Rev. 2014 Oct 12 [Epub ahead of print]
31. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
32. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
33. T. Minko, P. Kopeckova, V. Pozharov, K.D. Jensen, and J. Kopecek The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors Pharm. Res. 17 2000 505 514
34. S.E. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and J.M. DeSimone The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U. S. A. 105 2008 11613 11618
35. J.J. Khandare, and T. Minko Antibodies and peptides in cancer therapy Crit. Rev. Ther. Drug Carrier Syst. 23 2006 401 435
36. T. Minko Drug targeting to the colon with lectins and neoglycoconjugates Adv. Drug Deliv. Rev. 56 2004 491 509
37. T. Minko, R.I. Pakunlu, Y. Wang, J.J. Khandare, and M. Saad New generation of liposomal drugs for cancer Anticancer Agents Med Chem. 6 2006 537 552
38. M. Saad, O.B. Garbuzenko, E. Ber, P. Chandna, J.J. Khandare, V.P. Pozharov, and T. Minko Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J. Control. Release 130 2008 107 114
39. P.T. Cagle, Q.J. Zhai, L. Murphy, and P.S. Low Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents Arch. Pathol. Lab. Med. 137 2013 241 244
40. J. Shen, V. Chelvam, G. Cresswell, and P.S. Low Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma Mol. Pharm. 10 2013 1918 1927
41. M. Kverka, J.M. Hartley, T.W. Chu, J. Yang, R. Heidchen, and J. Kopecek Immunogenicity of coiled-coil based drug-free macromolecular therapeutics Biomaterials 35 2014 5886 5896
42. P. Chandna, M. Saad, Y. Wang, E. Ber, J. Khandare, A.A. Vetcher, V.A. Soldatenkov, and T. Minko Targeted proapoptotic anticancer drug delivery system Mol. Pharm. 4 2007 668 678
43. S.S. Dharap, B. Qiu, G.C. Williams, P. Sinko, S. Stein, and T. Minko Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides J. Control. Release 91 2003 61 73
44. S.S. Dharap, Y. Wang, P. Chandna, J.J. Khandare, B. Qiu, S. Gunaseelan, P.J. Sinko, S. Stein, A. Farmanfarmaian, and T. Minko Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide Proc. Natl. Acad. Sci. U. S. A. 102 2005 12962 12967
45. T. Minko, M.L. Patil, M. Zhang, J.J. Khandare, M. Saad, P. Chandna, and O. Taratula LHRH-targeted nanoparticles for cancer therapeutics Methods Mol. Biol. 624 2010 281 294
46. T. Minko, L. Rodriguez-Rodriguez, and V. Pozharov Nanotechnology approaches for personalized treatment of multidrug resistant cancers Adv. Drug Deliv. Rev. 65 2013 1880 1895
47. A.B. Watts, A.M. Cline, A.R. Saad, S.B. Johnson, J.I. Peters, and R.O. Williams III Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model Int. J. Pharm. 384 2010 46 52
48. A.B. Watts, J.I. Peters, R.L. Talbert, K.P. O'Donnell, J.J. Coalson, and R.O. Williams III Preclinical evaluation of tacrolimus colloidal dispersion for inhalation Eur. J. Pharm. Biopharm. 77 2011 207 215
49. T. Minko, J.J. Khandare, A.A. Vetcher, V.A. Soldatenkov, O.B. Garbuzenko, M. Saad, and V.P. Pozharov V.P. Torchilin, Multifunctional Pharmaceutical Nanocarriers 2008 Springer Science & Business Media 309 335
50. M. Vert, Y. Doi, K.-H. Hellwich, M. Hess, P. Hodge, P. Kubisa, M. Rinaudo, and S. François Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) Pure Appl. Chem. 84 2012 377 410
51. S. Alipour, H. Montaseri, and M. Tafaghodi Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery Colloids Surf. B: Biointerfaces 81 2010 521 529
52. B.C. Tang, J. Fu, D.N. Watkins, and J. Hanes Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo Biomaterials 31 2010 339 344
53. K. Tomoda, T. Ohkoshi, K. Hirota, G.S. Sonavane, T. Nakajima, H. Terada, M. Komuro, K. Kitazato, and K. Makino Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer Colloids Surf. B: Biointerfaces 71 2009 177 182
54. L.M. Kaminskas, V.M. McLeod, G.M. Ryan, B.D. Kelly, J.M. Haynes, M. Williamson, N. Thienthong, D.J. Owen, and C.J. Porter Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy J. Control. Release 183 2014 18 26
55. M.L. Patil, M. Zhang, S. Betigeri, O. Taratula, H. He, and T. Minko Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery Bioconjug. Chem. 19 2008 1396 1403
56. M.L. Patil, M. Zhang, and T. Minko Multifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing ACS Nano 5 2011 1877 1887
57. M.L. Patil, M. Zhang, O. Taratula, O.B. Garbuzenko, H. He, and T. Minko Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting Biomacromolecules 10 2009 258 266
58. V. Shah, O. Taratula, O.B. Garbuzenko, M.L. Patil, R. Savla, M. Zhang, and T. Minko Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids Curr. Drug Discov. Technol. 10 2013 8 15
59. O. Taratula, O. Garbuzenko, R. Savla, Y.A. Wang, H. He, and T. Minko Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes Curr. Drug Deliv. 8 2011 59 69
60. O. Taratula, O.B. Garbuzenko, P. Kirkpatrick, I. Pandya, R. Savla, V.P. Pozharov, H. He, and T. Minko Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery J. Control. Release 140 2009 284 293
61. D. Wang, J.P. Kopeckova, T. Minko, V. Nanayakkara, and J. Kopecek Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers Biomacromolecules 1 2000 313 319
62. V. Shah, O. Taratula, O.B. Garbuzenko, O.R. Taratula, L. Rodriguez-Rodriguez, and T. Minko Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug Clin. Cancer Res. 19 2013 6193 6204
63. S.A. Meenach, K.W. Anderson, J. Zach Hilt, R.C. McGarry, and H.M. Mansour Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer Eur. J. Pharm. Sci. 49 2013 699 711
64. S.A. Meenach, K.W. Anderson, J.Z. Hilt, R.C. McGarry, and H.M. Mansour High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies AAPS PharmSciTech 15 2014 1574 1587
65. A. Etzerodt, M.B. Maniecki, J.H. Graversen, H.J. Moller, V.P. Torchilin, and S.K. Moestrup Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163 J. Control. Release 160 2012 72 80
66. T.S. Levchenko, W.C. Hartner, and V.P. Torchilin Liposomes in diagnosis and treatment of cardiovascular disorders Methodist Debakey Cardiovasc. J. 8 2012 36 41
67. V.P. Torchilin Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents Immunomethods 4 1994 244 258
68. V.P. Torchilin, and T.S. Levchenko TAT-liposomes: a novel intracellular drug carrier Curr. Protein Pept. Sci. 4 2003 133 140
69. S. Betigeri, M. Zhang, O. Garbuzenko, and T. Minko Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage Drug Deliv. Transl. Res. 1 2011 13 24
70. T. Minko, A. Stefanov, and V. Pozharov Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol J. Appl. Physiol. 93 2002 1985 1550 1560 (discussion 1549)
71. L. Willis, D. Hayes Jr., and H.M. Mansour Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery Lung 190 2012 251 262
72. R.I. Pakunlu, Y. Wang, W. Tsao, V. Pozharov, T.J. Cook, and T. Minko Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system Cancer Res. 64 2004 6214 6224
73. M. Saad, O.B. Garbuzenko, and T. Minko Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer Nanomedicine (Lond.) 3 2008 761 776
74. Y. Wang, M. Saad, R.I. Pakunlu, J.J. Khandare, O.B. Garbuzenko, A.A. Vetcher, V.A. Soldatenkov, V.P. Pozharov, and T. Minko Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor Clin. Cancer Res. 14 2008 3607 3616
75. J. Merian, R. De Souza, Y. Dou, S.N. Ekdawi, F. Ravenelle, and C. Allen Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications Int. J. Pharm. 488 2015 154 164
76. B. Pitard, M. Bello-Roufai, O. Lambert, P. Richard, L. Desigaux, S. Fernandes, C. Lanctin, H. Pollard, M. Zeghal, P.Y. Rescan, and D. Escande Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer Nucleic Acids Res. 32 2004 e159
77. P. Richard-Fiardo, B. Cambien, E. Pradelli, F. Beilvert, B. Pitard, H. Schmid-Antomarchi, and A. Schmid-Alliana Effect of fractalkine-Fc delivery in experimental lung metastasis using DNA/704 nanospheres Cancer Gene Ther. 18 2011 761 772
78. I.K. Park, S.E. Cook, Y.K. Kim, H.W. Kim, M.H. Cho, H.J. Jeong, E.M. Kim, J.W. Nah, H.S. Bom, and C.S. Cho Glucosylated polyethylenimine as a tumor-targeting gene carrier Arch. Pharm. Res. 28 2005 1302 1310
79. Y.K. Kim, C.S. Cho, M.H. Cho, and H.L. Jiang Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy J. Biomed. Mater. Res. A 102 2014 2230 2237
80. Z. Mohammadi, F.A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A.R. Najafabadi, and M.R. Tehrani In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung Int. J. Pharm. 421 2011 183 188
81. A.M. Chen, O. Taratula, D. Wei, H.I. Yen, T. Thomas, T.J. Thomas, T. Minko, and H. He Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes ACS Nano 4 2010 3679 3688
82. M. Beck-Broichsitter, O.M. Merkel, and T. Kissel Controlled pulmonary drug and gene delivery using polymeric nano-carriers J. Control. Release 161 2012 214 224
83. P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, J. Rosenecker, and C. Rudolph Targeted delivery of magnetic aerosol droplets to the lung Nat. Nanotechnol. 2 2007 495 499
84. D. Upadhyay, S. Scalia, R. Vogel, N. Wheate, R.O. Salama, P.M. Young, D. Traini, and W. Chrzanowski Magnetised thermo responsive lipid vehicles for targeted and controlled lung drug delivery Pharm. Res. 29 2012 2456 2467
85. N.K. Verma, K. Crosbie-Staunton, A. Satti, S. Gallagher, K.B. Ryan, T. Doody, C. McAtamney, R. MacLoughlin, P. Galvin, C.S. Burke, Y. Volkov, and Y.K. Gun'ko Magnetic core-shell nanoparticles for drug delivery by nebulization J. Nanobiotechnol. 11 2013 1
86. I. Gonda Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract Crit. Rev. Ther. Drug Carrier Syst. 6 1990 273 313
87. P.C. Kwok, and H.K. Chan Delivery of inhalation drugs to children for asthma and other respiratory diseases Adv. Drug Deliv. Rev. 73 2014 83 88
88. J.E. Frampton Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids Drugs 72 2012 1229 1241
89. W.E. Berger, and M.J. Noonan Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler J. Asthma 47 2010 447 459
90. M. Molimard, D. Till, S. Stenglein, D. Singh, and M. Krummen Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD Curr. Med. Res. Opin. 23 2007 2405 2413
91. P.L. McCormack, and K.A. Lyseng-Williamson Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma Drugs 67 2007 2407 2431
92. T. Minko, Y. Wang, and V. Pozharov Remediation of cellular hypoxic damage by pharmacological agents Curr. Pharm. Des. 11 2005 3185 3199
93. P. Sinswat, K.A. Overhoff, J.T. McConville, K.P. Johnston, and R.O. Williams III Nebulization of nanoparticulate amorphous or crystalline tacrolimus - single-dose pharmacokinetics study in mice Eur. J. Pharm. Biopharm. 69 2008 1057 1066
94. J. Li, C.R. Rayner, R.L. Nation, R.J. Owen, D. Spelman, K.E. Tan, and L. Liolios Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii Antimicrob. Agents Chemother. 50 2006 2946 2950
95. W. Yang, K.T. Chow, B. Lang, N.P. Wiederhold, K.P. Johnston, and R.O. Williams III In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution Eur. J. Pharm. Sci. 39 2010 336 347
96. J.A. Tolman, N.P. Wiederhold, J.T. McConville, L.K. Najvar, R. Bocanegra, J.I. Peters, J.J. Coalson, J.R. Graybill, T.F. Patterson, and R.O. Williams III Inhaled voriconazole for prevention of invasive pulmonary aspergillosis Antimicrob. Agents Chemother. 53 2009 2613 2615
97. R. Patil, A.V. Ljubimov, P.R. Gangalum, H. Ding, J. Portilla-Arias, S. Wagner, S. Inoue, B. Konda, A. Rekechenetskiy, A. Chesnokova, J.L. Markman, V.A. Ljubimov, D. Li, R.S. Prasad, K.L. Black, E. Holler, and J.Y. Ljubimova MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain ACS Nano 9 2015 5594 5608
98. T.C. Carvalho, S.R. Carvalho, and J.T. McConville Formulations for pulmonary administration of anticancer agents to treat lung malignancies J. Aerosol Med. Pulm. Drug Deliv. 24 2011 61 80
99. P. Zarogoulidis, E. Eleftheriadou, I. Sapardanis, V. Zarogoulidou, H. Lithoxopoulou, T. Kontakiotis, N. Karamanos, G. Zachariadis, M. Mabroudi, A. Zisimopoulos, and K. Zarogoulidis Feasibility and effectiveness of inhaled carboplatin in NSCLC patients Investig. New Drugs 30 2012 1628 1640
100. P. Zarogouldis, N.K. Karamanos, K. Porpodis, K. Domvri, H. Huang, W. Hohenforst-Schimdt, E.P. Goldberg, and K. Zarogoulidis Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology Int. J. Mol. Sci. 13 2012 10828 10862
101. A. Maillet, L. Guilleminault, E. Lemarie, S. Lerondel, N. Azzopardi, J. Montharu, N. Congy-Jolivet, P. Reverdiau, B. Legrain, C. Parent, D.H. Douvin, J. Hureaux, Y. Courty, M. De Monte, P. Diot, G. Paintaud, A. Le Pape, H. Watier, and N. Heuze-Vourc'h The airways, a novel route for delivering monoclonal antibodies to treat lung tumors Pharm. Res. 28 2011 2147 2156
102. A.M. Chen, M. Zhang, D. Wei, D. Stueber, O. Taratula, T. Minko, and H. He Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells Small 5 2009 2673 2677
103. L.Y. Peddada, O.B. Garbuzenko, D.I. Devore, T. Minko, and C.M. Roth Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes J. Control. Release 194 2014 103 112
104. Y. Wang, and T. Minko A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug Biochem. Pharmacol. 68 2004 2031 2042
105. M. Zhang, O.B. Garbuzenko, K.R. Reuhl, L. Rodriguez-Rodriguez, and T. Minko Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases Nanomedicine (Lond) 7 2012 185 197
106. D.E. Zamora-Avila, P. Zapata-Benavides, M.A. Franco-Molina, S. Saavedra-Alonso, L.M. Trejo-Avila, D. Resendez-Perez, J.L. Mendez-Vazquez, J. Isaias-Badillo, and C. Rodriguez-Padilla WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth Cancer Gene Ther. 16 2009 892 899
107. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia J. Am. Chem. Soc. 93 1971 2325 2327
108. R. Bharadwaj, and H. Yu The spindle checkpoint, aneuploidy, and cancer Oncogene 23 2004 2016 2027
109. D.A. Brito, Z. Yang, and C.L. Rieder Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied J. Cell Biol. 182 2008 623 629
110. N. Joshi, T. Shanmugam, A. Kaviratna, and R. Banerjee Proapoptotic lipid nanovesicles: synergism with paclitaxel in human lung adenocarcinoma A549 cells J. Control. Release 156 2011 413 420
111. N. El-Gendy, and C. Berkland Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration Pharm. Res. 26 2009 1752 1763
112. R.L. Momparler, M. Karon, S.E. Siegel, and F. Avila Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells Cancer Res. 36 1976 2891 2895
113. N.D. James, R.J. Coker, D. Tomlinson, J.R. Harris, M. Gompels, A.J. Pinching, and J.S. Stewart Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS Clin. Oncol. (R. Coll. Radiol.) 6 1994 294 296
114. M.M. Gaspar, A. Radomska, O.L. Gobbo, U. Bakowsky, M.W. Radomski, and C. Ehrhardt Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats J. Aerosol Med. Pulm. Drug Deliv. 25 2012 310 318
115. W.H. Roa, S. Azarmi, M.H. Al-Hallak, W.H. Finlay, A.M. Magliocco, and R. Lobenberg Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model J. Control. Release 150 2011 49 55
116. K. Legarza, and L.X. Yang New molecular mechanisms of action of camptothecin-type drugs Anticancer Res. 26 2006 3301 3305
117. M.K. Chung, S.S. Han, and J.C. Kim Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats Regul. Toxicol. Pharmacol. 45 2006 273 281
118. W. Hu, C. Zhang, W. Hu, Y. Fang, and W. Hou Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice Fitoterapia 83 2012 1291 1298
119. S. Pereira, P.A. Fernandes, and M.J. Ramos Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine J. Comput. Chem. 25 2004 1286 1294
120. P. Zarogoulidis, K. Darwiche, G. Kalamaras, H. Huang, W. Hohenforst-Schmidt, and K. Zarogoulidis Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer Transl. Lung Cancer Res. 2 2013 E17 E22
121. A. Cihak Biological effects of 5-azacytidine in eukaryotes Oncology 30 1974 405 422
122. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
123. T. Tatsumura, S. Koyama, M. Tsujimoto, M. Kitagawa, and S. Kagamimori Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical Br. J. Cancer 68 1993 1146 1149
124. P. Kalantarian, A.R. Najafabadi, I. Haririan, A. Vatanara, Y. Yamini, M. Darabi, and K. Gilani Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery Int. J. Nanomedicine 5 2010 763 770
125. J.M. Brand, B. Meller, K. Von Hof, J. Luhm, M. Bahre, H. Kirchner, and C. Frohn Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma Stem Cells Dev. 13 2004 307 314
126. R. Savla, O.B. Garbuzenko, S. Chen, L. Rodriguez-Rodriguez, and T. Minko Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy Pharm. Res. 31 2014 3487 3502
127. R.I. Pakunlu, Y. Wang, M. Saad, J.J. Khandare, V. Starovoytov, and T. Minko In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug J. Control. Release 114 2006 153 162
128. E. Terreno, F. Uggeri, and S. Aime Image guided therapy: the advent of theranostic agents J. Control. Release 161 2012 328 337
129. S. Dufort, A. Bianchi, M. Henry, F. Lux, G. Le Duc, V. Josserand, C. Louis, P. Perriat, Y. Cremillieux, O. Tillement, and J.L. Coll Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization Small 11 2015 215 221
130. P.M. Anderson, S.N. Markovic, J.A. Sloan, M.L. Clawson, M. Wylam, C.A. Arndt, W.A. Smithson, P. Burch, M. Gornet, and E. Rahman Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases Clin. Cancer Res. 5 1999 2316 2323
131. C.A. Arndt, N.V. Koshkina, C.Y. Inwards, D.S. Hawkins, M.D. Krailo, D. Villaluna, P.M. Anderson, A.M. Goorin, M.L. Blakely, M. Bernstein, S.A. Bell, K. Ray, D.C. Grendahl, N. Marina, and E.S. Kleinerman Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group Clin. Cancer Res. 16 2010 4024 4030
132. S.N. Markovic, V.J. Suman, W.K. Nevala, L. Geeraerts, E.T. Creagan, L.A. Erickson, K.M. Rowland Jr., R.F. Morton, W.L. Horvath, and M.R. Pittelkow A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study Am. J. Clin. Oncol. 31 2008 573 579
133. R.D. Rao, P.M. Anderson, C.A. Arndt, P.J. Wettstein, and S.N. Markovic Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer Am. J. Clin. Oncol. 26 2003 493 498
134. E. Esteban-Gonzalez, J. Carballido, V. Navas, Z. Torregrosa, A. Munoz, M.A. de Mon. PortugueseSpanish Inhaled Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2 Anticancer Drugs 18 2007 291 296
135. E. Huland, A. Burger, J. Fleischer, P. Fornara, E. Hatzmann, A. Heidenreich, H. Heinzer, H. Heynemann, L. Hoffmann, R. Hofmann, H. Huland, I. Kampfer, M. Kindler, H. Kirchner, G. Mehlhorn, T.H. Moniak, U. Rebmann, J. Roigas, T.H. Schneider, D. Schnorr, H.J. Schmitz, R. Wenisch, Z. Varga, and J. Vinke Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study Folia Biol. (Praha) 49 2003 183 190
136. O. Merimsky Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2 Ann. Oncol. 15 2004 610 612
137. C. Posch, F. Weihsengruber, K. Bartsch, V. Feichtenschlager, M. Sanlorenzo, I. Vujic, B. Monshi, S. Ortiz-Urda, and K. Rappersberger Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients Br. J. Cancer 110 2014 1427 1432
138. E. Lemarie, L. Vecellio, J. Hureaux, C. Prunier, C. Valat, D. Grimbert, M. Boidron-Celle, B. Giraudeau, A. le Pape, E. Pichon, P. Diot, A. el Houfia, and F. Gagnadoux Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study J. Aerosol Med. Pulm. Drug Deliv. 24 2011 261 270
139. G.A. Otterson, M.A. Villalona-Calero, W. Hicks, X. Pan, J.A. Ellerton, S.N. Gettinger, and J.R. Murren Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer Clin. Cancer Res. 16 2010 2466 2473
140. G.A. Otterson, M.A. Villalona-Calero, S. Sharma, M.G. Kris, A. Imondi, M. Gerber, D.A. White, M.J. Ratain, J.H. Schiller, A. Sandler, M. Kraut, S. Mani, and J.R. Murren Phase I study of inhaled doxorubicin for patients with metastatic tumors to the lungs Clin. Cancer Res. 13 2007 1246 1252
141. A.J. Chou, R. Gupta, M.D. Bell, K.O. Riewe, P.A. Meyers, and R. Gorlick Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung Pediatr. Blood Cancer 60 2013 580 586
142. C.F. Verschraegen, B.E. Gilbert, E. Loyer, A. Huaringa, G. Walsh, R.A. Newman, and V. Knight Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies Clin. Cancer Res. 10 2004 2319 2326
143. B.P. Wittgen, P.W. Kunst, K. van der Born, A.W. van Wijk, W. Perkins, F.G. Pilkiewicz, R. Perez-Soler, S. Nicholson, G.J. Peters, and P.E. Postmus Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung Clin. Cancer Res. 13 2007 2414 2421
144. U. Griesenbach, K.M. Pytel, and E.W. Alton Cystic fibrosis gene therapy in the UK and elsewhere Hum. Gene Ther. 26 2015 266 275
145. R.B. Moss, C. Milla, J. Colombo, F. Accurso, P.L. Zeitlin, J.P. Clancy, L.T. Spencer, J. Pilewski, D.A. Waltz, H.L. Dorkin, T. Ferkol, M. Pian, B. Ramsey, B.J. Carter, D.B. Martin, and A.E. Heald Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial Hum. Gene Ther. 18 2007 726 732
146. R.B. Moss, D. Rodman, L.T. Spencer, M.L. Aitken, P.L. Zeitlin, D. Waltz, C. Milla, A.S. Brody, J.P. Clancy, B. Ramsey, N. Hamblett, and A.E. Heald Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial Chest 125 2004 509 521
147. E. Alton, M. Stern, R. Farley, A. Jaffe, S.L. Chadwick, J. Phillips, J. Davies, S.N. Smith, J. Browning, M.G. Davies, M.E. Hodson, S.R. Durham, D. Li, P.K. Jeffery, M. Scallan, R. Balfour, S.J. Eastman, S.H. Cheng, A.E. Smith, D. Meeker, and D.M. Geddes Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial Lancet 353 1999 947 954
148. S.C. Hyde, K.W. Southern, U. Gileadi, E.M. Fitzjohn, K.A. Mofford, B.E. Waddell, H.C. Gooi, C.A. Goddard, K. Hannavy, S.E. Smyth, J.J. Egan, F.L. Sorgi, L. Huang, A.W. Cuthbert, M.J. Evans, W.H. Colledge, C.F. Higgins, A.K. Webb, and D.R. Gill Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis Gene Ther. 7 2000 1156 1165
149. P.G. Noone, K.W. Hohneker, Z. Zhou, L.G. Johnson, C. Foy, C. Gipson, K. Jones, T.L. Noah, M.W. Leigh, C. Schwartzbach, J. Efthimiou, R. Pearlman, R.C. Boucher, and M.R. Knowles Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis Mol. Ther. 1 2000 105 114
150. F.E. Ruiz, J.P. Clancy, M.A. Perricone, Z. Bebok, J.S. Hong, S.H. Cheng, D.P. Meeker, K.R. Young, R.A. Schoumacher, M.R. Weatherly, L. Wing, J.E. Morris, L. Sindel, M. Rosenberg, F.W. van Ginkel, J.R. McGhee, D. Kelly, R.K. Lyrene, and E.J. Sorscher A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis Hum. Gene Ther. 12 2001 751 761
151. E.W. Alton, A.C. Boyd, S.H. Cheng, S. Cunningham, J.C. Davies, D.R. Gill, U. Griesenbach, T. Higgins, S.C. Hyde, J.A. Innes, G.D. Murray, and D.J. Porteous A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis Thorax 68 2013 1075 1077
152. W.C. Chin, E.Y.T. Chen, Y.C. Wang, Nanoparticle based therapy for dispersing mucin. Google Patents, 2014.
153. J. Geiger, M.K. Aneja, C. Rudolph, Pulmonary Delivery of Messenger RNA. Google Patents, 2015.
154. M. Heartlein, B.C. Guild, F. DeRosa, C. Rudolph, C. Plank, L. Smith, Cftr mrna compositions and related methods and uses. Google Patents, 2015.
155. H.D. Smyth, M.J. Donovan, Swellable particles for drug delivery. Google Patents, 2013.
156. T. Minko, O.B. Garbuzenko, V. Ivanova, Nanotechnology approach for inhalation therapies. Google Patents, 2013.
157. M. Bradbury, U. Wiesner, M.O. Penate, A. Burns, J. Lewis, S. Larson, T. Quinn, Multimodal silica-based nanoparticles. Google Patents, 2014.
158. W.Z. Ong, P.W. Nowak, J. Kim, E.M. Enlow, J. BOURASSA, Y. CU, A. Popov, H. Chen, Meropenem derivatives and uses thereof. Google Patents, 2014.
159. M. Hartman, T.E. Tarara, P. Teung, J.G. Weers, Respirable agglomerates of porous carrier particles and micronized drug. Google Patents, 2014.